“…49 Yotsumoto et al 49 reported a case of a 36-year-old male with idiopathic follicular mucinosis that responded within two weeks to minocycline with no recurrence. We chose not to continue the patient on oral steroids because of the long-term potential consequences.…”
Section: Discussionmentioning
confidence: 98%
“…49 In vitro studies have shown that minocycline has the ability to inhibit epidermal keratinocyte production of TNF-A and increase the production of IL-1A. 49, 60 Yotsumoto et al 49 proposed the theory that minocycline decreases TNF-A production by inhibiting tissue matrix metalloproteinases, which are required for posttranslational processing of TNF-A. 49 There is evidence that cell-mediated immunity plays a role in the pathogenesis of alopecia mucinosa.…”
Section: Discussionmentioning
confidence: 98%
“…49 Minocycline is not only an antimicrobial agent; it has been shown to inhibit matrix metalloproteinases (e.g., collagenase), 59 phospholipase A2, 59 polymorphonuclear cell chemotaxis, and nitric oxide production. 49 In vitro studies have shown that minocycline has the ability to inhibit epidermal keratinocyte production of TNF-A and increase the production of IL-1A.…”
Section: Discussionmentioning
confidence: 99%
“…49 Minocycline is not only an antimicrobial agent; it has been shown to inhibit matrix metalloproteinases (e.g., collagenase), 59 phospholipase A2, 59 polymorphonuclear cell chemotaxis, and nitric oxide production. 49 In vitro studies have shown that minocycline has the ability to inhibit epidermal keratinocyte production of TNF-A and increase the production of IL-1A. 49, 60 Yotsumoto et al 49 proposed the theory that minocycline decreases TNF-A production by inhibiting tissue matrix metalloproteinases, which are required for posttranslational processing of TNF-A.…”
We report a case of idiopathic alopecia mucinosa that responded to minocycline with a complete remission and we review the literature on alopecia mucinosa.
“…49 Yotsumoto et al 49 reported a case of a 36-year-old male with idiopathic follicular mucinosis that responded within two weeks to minocycline with no recurrence. We chose not to continue the patient on oral steroids because of the long-term potential consequences.…”
Section: Discussionmentioning
confidence: 98%
“…49 In vitro studies have shown that minocycline has the ability to inhibit epidermal keratinocyte production of TNF-A and increase the production of IL-1A. 49, 60 Yotsumoto et al 49 proposed the theory that minocycline decreases TNF-A production by inhibiting tissue matrix metalloproteinases, which are required for posttranslational processing of TNF-A. 49 There is evidence that cell-mediated immunity plays a role in the pathogenesis of alopecia mucinosa.…”
Section: Discussionmentioning
confidence: 98%
“…49 Minocycline is not only an antimicrobial agent; it has been shown to inhibit matrix metalloproteinases (e.g., collagenase), 59 phospholipase A2, 59 polymorphonuclear cell chemotaxis, and nitric oxide production. 49 In vitro studies have shown that minocycline has the ability to inhibit epidermal keratinocyte production of TNF-A and increase the production of IL-1A.…”
Section: Discussionmentioning
confidence: 99%
“…49 Minocycline is not only an antimicrobial agent; it has been shown to inhibit matrix metalloproteinases (e.g., collagenase), 59 phospholipase A2, 59 polymorphonuclear cell chemotaxis, and nitric oxide production. 49 In vitro studies have shown that minocycline has the ability to inhibit epidermal keratinocyte production of TNF-A and increase the production of IL-1A. 49, 60 Yotsumoto et al 49 proposed the theory that minocycline decreases TNF-A production by inhibiting tissue matrix metalloproteinases, which are required for posttranslational processing of TNF-A.…”
We report a case of idiopathic alopecia mucinosa that responded to minocycline with a complete remission and we review the literature on alopecia mucinosa.
“…Corticosteroids, dapsone, minocycline, superficial X-ray, indomethacin, and interferons have been used with various results in individual cases 1,[3][4][5][6][7] . However, effective therapeutic options for FM have remained elusive.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.